Compare AEON & BESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEON | BESS |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | 8 | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 20.9M |
| IPO Year | N/A | N/A |
| Metric | AEON | BESS |
|---|---|---|
| Price | $0.92 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 122.6K | 31.0K |
| Earning Date | 05-14-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $2.06 |
| 52 Week High | $1.45 | $3.60 |
| Indicator | AEON | BESS |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 41.91 |
| Support Level | $0.91 | $2.06 |
| Resistance Level | $1.12 | $3.09 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 15.63 | 42.57 |
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.